Written by a parent, not a doctor. Nothing here is medical advice.

Childhood Cancer Lantern
Search Saved

Texas program

Deadlines the plan must meet on prior authorization

Texas limits how an insured plan tells you it has refused care. Your doctor can also challenge a cheaper-drug-first rule.

What it is

Texas limits how an insured plan tells you it has refused care. Your doctor can also challenge a cheaper-drug-first rule.

A stalled treatment request can leave your family waiting without a clear answer. Texas sets deadlines for denial notices and exceptions to some drug restrictions. The hospital nurse who handles insurance requests can check which rule applies to your plan.

Who this can help
  • These provisions mainly govern Texas-regulated insured coverage. Private-employer self-funded plans are outside the TDI preauthorization-exemption rule; Medicaid and CHIP use separate rules.
  • TDI includes regulated Marketplace coverage and ERS/TRS plans in the doctor’s preauthorization-exemption rule. That does not establish which other chapter 4201 duties apply to each public plan.
  • If a parent works for the state, a school district or a state university, the plan follows some of these Texas deadlines but not all of them. The hospital's insurance nurse can check which ones apply.
What you get
  • No fee to raise a missed notice deadline.
  • Thirty days’ notice before some ongoing drugs or infusions are stopped.
  • Exceptions to trying another drug first when the doctor documents a qualifying reason.
What the rules cover
  • If the plan refuses care while your child is in hospital, it must tell the doctor within one working day and send you a letter within three. Other refusals get a letter within three working days.
  • A denial of requested post-stabilization care has a one-hour notice deadline after the request. The separate 30-day advance notice before stopping a drug or infusion under concurrent review does not apply to the public programs excluded by section 4201.053(b), including ERS, TRS and UT/A&M coverage.
  • Since September 1, 2025, the service-specific preauthorization exemption uses a 90% approval record and at least five services in the one-year evaluation period. A doctor denied the exemption can seek independent review.
  • A step-therapy exception needs the prescriber’s documented statement: the required drug is contraindicated, harmful or expected to fail; an earlier same-class drug failed or caused harm; the drug is clinically inappropriate; or the child is stable and switching would likely fail or cause harm.
  • For applicable Texas-regulated drug coverage issued or renewed from January 1, 2024, certain third-party payments or discounts must count toward your cost-sharing. The covered drug must have no generic or interchangeable alternative, or the required exception must be approved. The hospital pharmacy team can check the plan, drug and deductible record. This protection does not automatically apply to a self-funded work plan.
  • An applicable step-therapy exception request has a 72-hour ordinary response deadline or 24 hours when urgent. A missed response can mean approval under the applicable rule. The pharmacy team can confirm the plan’s scope and when it received the request.
If you decide to apply
  1. Ask the hospital nurse who handles insurance requests to check your plan type and log each request’s date.
  2. Give the nurse the denial letter and ask the oncologist to document why a drug restriction would be unsafe.
  3. Ask the nurse about a TDI complaint if the plan misses a notice deadline.

TDI: 800-252-3439 · Official page ↗

What happens next
  • The oncology team supplies the medical evidence and any request for urgent handling. TDI handles complaints about rules within its authority.
  • An exemption for one service does not excuse every insurance request from that doctor.
Good to know

These are mainly deadlines for telling you about a denial. They are not a promise that every request must be approved within that time.

Other details
  • The one-authorization-per-year law for specified autoimmune and bleeding-disorder drugs does not cover leukemia drugs. It applies to relevant policies issued or renewed from January 1, 2024.
Official sources
Ask your social worker

“If the plan delays treatment or wants a different drug first, which deadline or exception applies, and can the hospital nurse help us use it?”

Why I’m asking: I want to know whether an insurance delay can be challenged before it disrupts care.

More background and detailed requirements
Additional program information and published rules

Who does what

The three parts, side by side. The agency decides; nobody on this page does.

You

Ask HR whether the plan is fully insured. Keep every denial letter with the date it arrived. Ask the clinic to mark chemo requests urgent.

Your social worker

Connects you to the hospital's authorization nurse, who logs each request and knows the plan's fax and phone.

The care team

Files the request, documents the step-therapy exception grounds, and asks for the exemption when the doctor's approval record supports it.

Who decides
The plan's utilization-review agent decides the authorization. TDI enforces the deadlines on complaint
Ask the care team
“When the plan denies or delays an authorization, who logs the date and time? If the plan asks for a cheaper drug first, can you document a step-therapy exception?”

How to apply

First step: Ask HR whether the plan is fully insured. Then ask the clinic's authorization nurse to log every request and mark chemo requests urgent.

  1. When a request goes in, ask the authorization nurse for the date and time and whether it was marked urgent. If a denial arrives late or a drug is stopped without 30 days' notice, call TDI at 800-252-3439.

Official application / program page ↗

Where it starts: Ask the hospital's authorization nurse to file requests as urgent and log dates; call TDI at 800-252-3439 when a notice deadline is missed

What to gather

  • The denial letter and the date and time it arrived
  • The request date from the authorization nurse
  • HR's answer on fully insured versus self-funded
  • The doctor's step-therapy exception letter, if a cheaper drug was required first

How long: Denial notice: one working day by phone while inpatient (letter within three working days), three working days otherwise, one hour for post-stabilization care. 30 days' notice before an ongoing drug or infusion stops.

What a yes looks like

An approval, or a denial letter that arrived inside the deadline with the clinical reason and appeal instructions.

What a no looks like, and the next move

A denial past the deadline, or a drug stopped without 30 days' notice. Call TDI at 800-252-3439 and start the appeal the same day.

Watch out

  • The clocks are for telling you about a denial. Ask the authorization nurse to mark chemo requests urgent and log the date and time of each one.
  • Private-employer self-funded plans are outside TDI’s gold-card rule. ERS/TRS state employee and teacher plans are expressly included for that exemption; ask your administrator which other authorization provisions apply.
  • The one-authorization-a-year law from 2023 covers autoimmune disease and bleeding disorders, not leukemia drugs.
  • TRS-ActiveCare and ERS have separate appeal procedures. TRS’s administrator removed medical prior authorization for its administrative-services arrangement in September 2024; that does not settle every benefit or local public plan. Ask which document applies.
  • The historical 2015 enactment excluded specified public plans from four named provisions, not all of chapter 4201. TDI’s gold-card FAQ includes regulated Marketplace and ERS/TRS plans. This does not establish every public-plan denial clock or override a plan’s distinct appeal process.

If they say no, quote this: Insurance Code 4201.304 (notice deadlines), 4201.653 (preauthorization exemption, HB 3812, 2025) and 1369.0546(c) (step-therapy exception).

The numbers and the rules

The arcane layer, kept on purpose. Checked September 10, 2026.

What it is worth

Deadlines on an insured plan's prior-authorization denials (one working day inpatient, three working days otherwise, one hour for post-stabilization care) and 30 days' notice before an ongoing drug or infusion stops. A step-therapy exception the plan must grant when the doctor documents one of four reasons.

Legal protection: Denial notice within one working day by phone or electronic transmission while the patient is hospitalized, followed by a letter within three working days (4201.304(a)(1)) · Denial notice within three working days in writing when the patient is not hospitalized (4201.304(a)(2)) · Post-stabilization care denial within one hour of the request (4201.304(a)(3)) · Thirty days' notice before a drug or infusion under concurrent review is discontinued (4201.304(b)) · Preauthorization exemption for a doctor approved on 90% or more of requests for the service, five or more times in the one-year period (4201.653, HB 3812, effective 2025-09-01) · Step-therapy exception the plan must grant on the prescriber's documented statement (1369.0546(c))

What it costs the family: No fee.

The eligibility facts, as published

Plan
state-regulated (fully insured) plan; utilization-review agents under Insurance Code chapter 4201
Excluded
Private-employer self-funded plans are outside the TDI gold-card rule; Medicaid/CHIP use their own rules. TDI expressly includes ERS/TRS for gold-card exemptions. Other chapter 4201 duties have provision-specific public-plan exceptions; current consolidated applicability remains unverified.
Gold card
doctor approved (or would have been approved) on 90% or more of requests for that service in the one-year evaluation period and provided the service five or more times (4201.653, HB 3812, effective 2025-09-01); denial of the exemption gets an independent review (4201.656)
Step therapy exception
prescriber's written statement with documentation: the required drug is contraindicated, likely harmful or expected ineffective; the patient already stopped it or a same-class drug for ineffectiveness or an adverse event; the drug is clinically inappropriate (adherence, comorbidity, daily function); or the patient is stable on the prescribed drug and a switch is expected ineffective or harmful (1369.0546(c)(1)–(4))
Hb755
one prior authorization a year for autoimmune, hemophilia and Von Willebrand drugs on plans issued or renewed from 2024-01-01 (1369.654); its applicability names ch. 1551, 1575, 1579 and 1601 plans; leukemia drugs are not covered by it

The trap: The clocks run on the plan's notice of a denial, not on how long it thinks about a request. Ask the hospital's authorization nurse to log the date and time of every request and to mark chemo requests urgent.

Where I read this

← Back to your options